Private equity firm Veritas Capital and hedge fund Elliott Investment Management are exploring options for Athenahealth Inc, including a sale or initial public offering, Bloomberg News reported on Wednesday, citing people familiar with the matter.
Veritas and Elliott are aiming for the health information technology company to be valued at more than $20bn, the report said, adding that the firms hope to complete the deal by the end of the first quarter next year.
Veritas and Athenahealth declined to comment on the report, while Elliott did not immediately respond to Reuters’ request for comment.
Free Webinar: The Primary Step in Creating Value: How the Right Corporate Governance Can Drive Growth
- To what extend can the relationship between the GP and board impact the company?
- How can GPs ensure trickle down change in organisations?
- How can technology help bridge the gap between GPs and management boards?
As per the report, Veritas and Elliott are working with Goldman Sachs Group Inc and Evercore Inc to help explore options for Athenahealth.
The hedge fund and Veritas had partnered in 2018 for a $5.7bn deal to take Athenahealth private, after which the company was merged with a healthcare unit that Vertias had acquired from General Electric.
Source: Reuters
Can’t stop reading? Read more
Blackstone backs Permira’s £2.3bn JTC buyout with £1.5bn private credit package
Blackstone backs Permira’s £2.3bn JTC buyout with £1.5bn private credit package Blackstone has led...
Luckin investor Centurium in talks over £1bn Costa Coffee takeover
Luckin investor Centurium in talks over £1bn Costa Coffee takeover Centurium Capital, the Chinese...
“Cash is king, and anything else is an opinion”: private equity’s return to fundamentals
“Cash is king, and anything else is an opinion”: private equity’s return to fundamentals After a...